All Journal Entries Journals

Sources for --What you need to know about IR to increase SVR

Mar 15, 2009 - 2 comments

insulin resistance








Hepatitis C and insulin resistance: steatosis, fibrosis and non-response.

Insulin resistance and hepatitis C.

Insulin-Resistance in Chronic Hepatitis C patients: New Predictor of Sustained Virological Response Independent of HCV Genotype and Liver Fibrosis Stage.

Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin.

Insulin Resistance and Hyperinsulinemia. Is hyperinsulinemia the cart or the horse?

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.$=relatedarticles&logdbfrom=pubmed

Diabetes Mellitus Is Associated with Impaired Response to Antiviral Therapy in Chronic Hepatitis C Infection.

Glucose >100 mg/dl Reduces Interferon/RBV SVR

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.$=relatedarticles&logdbfrom=pubmed

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

Steatosis, Insulin resistance, Iron overload, Fibrosis and Viral load as negative factors affecting Early (EVR) and Sustained (SVR) Virological Response in patients with Chronic Hepatitis C treated with peginterferon and ribavirin.

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.$=citationsensor

Is HOMA-IR the best marker of insulin resistance in chronic hepatitis due to HCV infection?

Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.

Therapies to Manage Insulin Resistance Improve Response to Interferon-based Therapy in Chronic Hepatitis C Patients.

Influence of weight reduction on the effectiveness of combined peginterferon and ribavirin treatment in chronic HCV hepatitis.

Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.

Viral Kinetic Response to 12 Week Treatment with Rosiglitazone in Chronic Hepatitis C, Genotype 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin.

In Chronic Hepatitis C (HCV), Pretreatment with Thiazolidinediones (TZDs) or Metformin Decreases Insulin Resistance (IR) and HCV Viral Load and Increases Early Virologic Response (EVR).

Metformin with Peginterferon Alfa-2a and Ribavirin in the Treatment of Naïve Genotype 1 Chronic Hepatitis C Patients with Insulin Resistance (TRIC-1): Final Results of a Randomized and Double-Blinded Trial.

Pioglitazone improves early virologic kinetic response to Peg IFN/RBV combination therapy in hepatitis C genotype 1 naïve patients.

A Randomized, Double-Blind, Placebo-Controlled Study of PPAR-gamma Agonist Pioglitazone Given in Combination with Peginterferon and Ribavirin in Patients with Genotype-1 Chronic Hepatitis C.

Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load.

Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: Differences and similarities

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance.

OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself.$=relatedarticles&logdbfrom=pubmed

Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients$=relatedarticles&logdbfrom=pubmed

Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg/dL$=relatedarticles&logdbfrom=pubmed

Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.$=relatedarticles&logdbfrom=pubmed

Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects.

Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding.$=citationsensor

Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance.

Insulin resistance and lichen planus in patients with HCV-infectious liver diseases.

Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.$=relatedarticles&logdbfrom=pubmed

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.$=relatedarticles&logdbfrom=pubmed

Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.

Post a Comment
by geterdone, Mar 16, 2009
Nice reservoir of information on (IR) insulin resistance and the Hepatitis C patient. Why don’t you put this on the Health Page?


by CoWriter, Mar 17, 2009
In all honesty I had no idea what the "Health Page" was.  Yeah, maybe I'll do that.  Thanks Geter.  I'm adding one more to my collection.  This one shows that if you have a family history of diabetes, you're probably insulin resistant.  


Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients$=relatedarticles&logdbfrom=pubmed

Post a Comment